Prices delayed by at least 15 minutes | Print


Bristol-Myers Squibb Co (BMY)

Common Stock
Sell: $54|Buy: $54.72|Change: 0.98 (1.84%)

Open 

$53.39


Previous close 

$53.25


Trade high 

$54.475


Volume 

14,348,196


Year high 

$71.07


Year low 

$47.58


Dividend yield 

4.34%


Market capitalisation 

$109.66 bn


P/E ratio 

13.80


ISIN 

US1101221083


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date05/01/202405/04/2024
Ex-dividend date04/01/202404/04/2024
Payment date01/02/202401/05/2024
Amount$0.6$0.6

Performance 31/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Bristol-Myers Squibb Co+ 1.84
More...

Company profile

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.